Acumen Pharmaceuticals
$2.36
25
+$0.17+7.76% Tuesday 19:57
Statistics
Day High
2.42
Day Low
2.19
52W High
3.6
52W Low
0.86
Volume
405,232
Avg. Volume
855,601
Mkt Cap
142.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-0.373467
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-204.66MNet Income
Analyst Ratings
$8.00Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ABOS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Lilly(Eli) &
LLY
Mkt Cap772.28B
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Prothena
PRTA
Mkt Cap578.67M
Athira Pharma Inc
ATHA
Mkt Cap16.39M
Cass Information Systems
CASS
Mkt Cap516.78M
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Curis
CRIS
Mkt Cap18.62M
About
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Show more...
CEO
Mr. Daniel J. O'Connell M.B.A.
Employees
61
Country
US
ISIN
US00509G2093
Listings
0 Comments
Share your thoughts
FAQ
What is Acumen Pharmaceuticals stock price today?▼
The current price of ABOS is $2.36 USD — it has increased by +7.76% in the past 24 hours. Watch Acumen Pharmaceuticals stock price performance more closely on the chart.
What is Acumen Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acumen Pharmaceuticals stocks are traded under the ticker ABOS.
Is Acumen Pharmaceuticals stock price growing?▼
ABOS stock has fallen by -10.27% compared to the previous week, the month change is a -24.84% fall, over the last year Acumen Pharmaceuticals has showed a +119.53% increase.
What is Acumen Pharmaceuticals market cap?▼
Today Acumen Pharmaceuticals has the market capitalization of 142.95M
When is the next Acumen Pharmaceuticals earnings date?▼
Acumen Pharmaceuticals is going to release the next earnings report on May 19, 2026.
What were Acumen Pharmaceuticals earnings last quarter?▼
ABOS earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.45 USD resulting in a +11.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Acumen Pharmaceuticals revenue for the last year?▼
Acumen Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Acumen Pharmaceuticals net income for the last year?▼
ABOS net income for the last year is -204.66M USD.
How many employees does Acumen Pharmaceuticals have?▼
As of April 01, 2026, the company has 61 employees.
In which sector is Acumen Pharmaceuticals located?▼
Acumen Pharmaceuticals operates in the Health Care sector.
When did Acumen Pharmaceuticals complete a stock split?▼
Acumen Pharmaceuticals has not had any recent stock splits.
Where is Acumen Pharmaceuticals headquartered?▼
Acumen Pharmaceuticals is headquartered in Newton, US.